Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: Clinical evidence for pain relief and restoration of function via nerve fiber regeneration

被引:24
作者
Anand, Praveen [1 ]
Privitera, Rosario [1 ]
Donatien, Philippe [1 ]
Fadavi, Hassan [1 ]
Tesfaye, Solomon [2 ]
Bravis, Vassiliki [3 ]
Misra, V. Peter [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll London, Div Neurol, London, England
[2] Sheffield Teaching Hosp NHS Fdn Trust, Diabet Res Unit, Sheffield, England
[3] St Marys Hosp, Imperial Coll Healthcare NHS Trust, Dept Endocrinol & Diabet, London, England
关键词
capsaicin; diabetic neuropathy; pain; clinical trial; skin biopsy; INDUCED PERIPHERAL NEUROPATHY; GROWTH-FACTOR; DOUBLE-BLIND; QUTENZA; TRIAL;
D O I
10.3389/fneur.2022.998904
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionCurrent oral treatments for pain in diabetic peripheral neuropathy (DPN) do not affect the progression of DPN i.e., "disease modification." We assessed whether Capsaicin 8% patch treatment can provide pain relief and also restore nerve density and function via nerve regeneration, in both painful (PDPN) and non-painful (NPDPN) diabetic peripheral neuropathy. Methods50 participants with PDPN were randomized to receive Capsaicin 8% patch Qutenza with Standard of Care (SOC) (PDPN Q+SOC group), or SOC alone (PDPN SOC group). Pain symptoms were assessed with a diary (Numerical Pain Rating Scale, NRPS) and questionnaires. Investigations included quantitative sensory testing (QST) and distal calf skin biopsies, at baseline and 3 months after baseline visit; subsequent options were 3-monthly visits over 1 year. 25 participants with NPDPN had tests at baseline, and 3 months after all received Capsaicin 8% patch treatment. ResultsAt 3 months after baseline, PDPN Q+SOC group had reduction in NPRS score (p = 0.0001), but not PDPN SOC group. Short-Form McGill Pain Questionnaire (SF-MPQ) showed significant reductions in scores for overall and other pain descriptors only in the PDPN Q+SOC group. Warm perception thresholds were significantly improved only in the PDPN Q+SOC group (p = 0.02), and correlated with reduction in SF-MPQ overall pain score (p = 0.04). NPDPN Q+SOC group did not report pain during the entire study. Density of intra-epidermal nerve fibers (IENF) with PGP9.5 was increased at 3 months in PDPN Q+SOC (p = 0.0002) and NPDPN Q+SOC (p = 0.002) groups, but not in the PDPN SOC group. Increased sub-epidermal nerve fibers (SENF) were observed with GAP43 (marker of regenerating nerve fibers) only in PDPN Q+SOC (p = 0.003) and NPDPN Q+SOC (p = 0.0005) groups. Pain relief in the PDPN Q+SOC group was correlated with the increased PGP9.5 IENF (p = 0.0008) and GAP43 (p = 0.004), whereas those with lack of pain relief showed no such increase; in some subjects pain relief and increased nerve fibers persisted over months. PGP9.5 IENF increase correlated with axon-reflex vasodilatation in a NPDPN Q+SOC subset (p = 0.006). ConclusionsCapsaicin 8% patch can provide pain relief via nerve regeneration and restoration of function in DPN (disease modification). It may thereby potentially prevent diabetic foot complications, including ulcers.
引用
收藏
页数:18
相关论文
共 47 条
[1]   NERVE GROWTH-FACTOR REGULATES NOCICEPTION IN HUMAN HEALTH AND DISEASE [J].
ANAND, P .
BRITISH JOURNAL OF ANAESTHESIA, 1995, 75 (02) :201-208
[2]  
Anand P, 2004, PROG BRAIN RES, V146, P477
[3]   Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch [J].
Anand, P. ;
Bley, K. .
BRITISH JOURNAL OF ANAESTHESIA, 2011, 107 (04) :490-502
[4]   Nerve growth factor in diabetic neuropathy [J].
Anand, P .
LANCET, 1998, 352 (9140) :1629-1630
[5]   The role of endogenous nerve growth factor in human diabetic neuropathy [J].
Anand, P ;
Terenghi, G ;
Warner, G ;
Kopelman, P ;
WilliamsChestnut, RE ;
Sinicropi, DV .
NATURE MEDICINE, 1996, 2 (06) :703-707
[6]   Capsaicin 8% Patch Treatment in Non-Freezing Cold Injury: Evidence for Pain Relief and Nerve Regeneration [J].
Anand, Praveen ;
Privitera, Rosario ;
Donatien, Philippe ;
Misra, V. Peter ;
Woods, David R. .
FRONTIERS IN NEUROLOGY, 2021, 12
[7]   Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification [J].
Anand, Praveen ;
Elsafa, Enas ;
Privitera, Rosario ;
Naidoo, Kalnisha ;
Yiangou, Yiangos ;
Donatien, Philippe ;
Gabra, Hani ;
Wasan, Harpreet ;
Kenny, Laura ;
Rahemtulla, Amin ;
Misra, Peter .
JOURNAL OF PAIN RESEARCH, 2019, 12 :2039-2052
[8]   Trench Foot or non-Freezing cold injury as a Painful Vaso-neuropathy: clinical and skin Biopsy assessments [J].
Anand, Praveen ;
Privitera, Rosario ;
Yiangou, Yiangos ;
Donatien, Philippe ;
Birch, Rolfe ;
Misra, Peter .
FRONTIERS IN NEUROLOGY, 2017, 8
[9]   Diabetic Foot Ulcers and Their Recurrence [J].
Armstrong, David G. ;
Boulton, Andrew J. M. ;
Bus, Sicco A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (24) :2367-2375
[10]   Use of the novel contact heat evoked potential stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts [J].
Atherton, Duncan D. ;
Facer, Paul ;
Roberts, Katherine M. ;
Misra, V. Peter ;
Chizh, Boris A. ;
Bountra, Chas ;
Anand, Praveen .
BMC NEUROLOGY, 2007, 7 (1)